Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-02-08 09:52 Tx date 2024-02-05 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
477,658 | |
Filed 2023-08-11 11:02 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-5,707,305 vol |
407,658 | |
Filed 2023-08-11 10:58 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-479,036 vol |
34,216 | |
Filed 2023-01-24 15:30 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+150,000 vol |
513,252 | |
Filed 2023-01-24 15:29 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-150,000 vol |
0 | |
Filed 2023-01-24 15:28 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
Filed 2023-01-24 15:28 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
6,114,963 | |
Filed 2022-09-22 09:53 Tx date 2022-09-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,939
+4,300 vol $0.68 each |
363,252 | |
Filed 2022-09-22 09:52 Tx date 2022-09-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,895
+5,700 vol $0.68 each |
358,952 | |
Filed 2022-07-08 14:52 Tx date 2022-07-06 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
5,714,963 | |
Filed 2022-06-07 15:18 Tx date 2022-06-06 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,709
+1,762 vol $0.97 each |
353,252 | |
Filed 2022-06-07 15:17 Tx date 2022-06-06 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,940
+4,062 vol $0.97 each |
351,490 | |
Filed 2022-06-07 15:16 Tx date 2022-06-06 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,351
+1,400 vol $0.97 each |
347,428 | |
Filed 2022-06-07 15:16 Tx date 2022-06-06 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,679
+2,776 vol $0.97 each |
346,028 | |
Filed 2022-01-20 18:52 Tx date 2022-01-18 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
5,114,963 | |
Filed 2021-12-17 17:45 Tx date 2021-12-16 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,830
+2,520 vol $1.52 each |
343,252 | |
Filed 2021-12-17 17:44 Tx date 2021-12-16 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,794
+2,480 vol $1.53 each |
340,732 | |
Filed 2021-12-17 17:44 Tx date 2021-12-16 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,599
+5,000 vol $1.52 each |
338,252 | |
Filed 2021-12-17 17:43 Tx date 2021-12-16 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,774
+3,183 vol $1.50 each |
333,252 | |
Filed 2021-12-15 15:59 Tx date 2021-12-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,964
+1,754 vol $1.12 each |
330,069 | |
Filed 2021-12-15 15:59 Tx date 2021-12-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,549
+5,000 vol $1.11 each |
328,315 | |
Filed 2021-12-15 15:58 Tx date 2021-12-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,684
+3,246 vol $1.14 each |
323,315 | |
Filed 2021-12-15 15:58 Tx date 2021-12-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,641
+5,000 vol $1.13 each |
320,069 | |
Filed 2021-12-15 15:57 Tx date 2021-12-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,160
+2,822 vol $1.12 each |
315,069 | |
Filed 2021-11-29 16:06 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$325.32
+143 vol $2.27 each |
312,247 | |
Filed 2021-11-29 16:06 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,136
+500 vol $2.27 each |
312,104 | |
Filed 2021-11-29 16:05 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,147
+500 vol $2.29 each |
311,604 | |
Filed 2021-11-29 16:04 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,149
+500 vol $2.30 each |
311,104 | |
Filed 2021-11-29 16:03 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$924.00
+400 vol $2.31 each |
310,604 | |
Filed 2021-11-29 16:02 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,385
+600 vol $2.31 each |
310,204 | |
Filed 2021-11-29 16:01 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,319
+1,000 vol $2.32 each |
309,604 | |
Filed 2021-11-29 15:59 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,319
+1,000 vol $2.32 each |
308,604 | |
Filed 2021-11-29 15:59 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,637
+2,000 vol $2.32 each |
307,604 | |
Filed 2021-11-29 15:55 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,328
+1,000 vol $2.33 each |
305,604 | |
Filed 2021-11-29 15:52 Tx date 2021-11-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,325
+1,000 vol $2.33 each |
304,604 | |
Filed 2021-07-06 17:34 Tx date 2021-07-02 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,277
+1,000 vol $3.28 each |
303,604 | |
Filed 2021-07-06 17:33 Tx date 2021-07-02 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,285
+1,000 vol $3.29 each |
302,604 | |
Filed 2021-07-06 17:32 Tx date 2021-07-02 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,556
+1,081 vol $3.29 each |
301,604 | |
Filed 2021-07-06 17:31 Tx date 2021-07-02 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,590
+2,000 vol $3.29 each |
300,523 | |
Filed 2021-07-06 17:30 Tx date 2021-07-02 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,280
+1,000 vol $3.28 each |
298,523 | |
Filed 2021-03-12 18:25 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
35,263 | |
Filed 2021-01-06 20:12 Tx date 2021-01-04 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+343,000 vol |
4,414,963 | |
Filed 2020-12-02 15:59 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,971 vol |
63,761 | |
Filed 2020-12-02 15:58 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
8,134 | |
Filed 2020-10-05 19:45 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,010 vol |
59,790 | |
Filed 2020-10-05 19:44 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-17,483 vol |
12,105 | |
Filed 2020-10-05 19:43 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
29,588 | |
Filed 2020-07-10 19:37 Tx date 2020-07-10 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,021,790.55
-168,891 vol $6.05 each |
297,523 | |
Filed 2020-07-10 19:35 Tx date 2020-07-10 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+300,000 vol |
466,414 | |
Filed 2020-07-10 19:34 Tx date 2020-07-10 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-300,000 vol |
0 | |
Filed 2020-03-26 16:20 Tx date 2020-03-25 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,802
+3,400 vol $5.82 each |
166,414 | |
Filed 2020-03-14 14:00 Tx date 2020-03-10 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+300,000 vol |
300,000 | |
Filed 2020-02-03 10:56 Tx date 2020-01-31 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
4,071,963 | |
Filed 2020-01-17 10:50 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,526 vol |
48,780 | |
Filed 2020-01-17 10:47 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-10,526 vol |
12,105 | |
Filed 2019-10-28 11:39 Tx date 2019-10-24 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,200
+10,000 vol $1.92 each |
163,014 | |
Filed 2019-10-08 09:49 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
22,631 | |
Filed 2019-10-08 09:45 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,182 vol |
38,254 | |
Filed 2019-10-08 09:44 Tx date 2019-10-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
||
Filed 2019-10-04 10:43 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+27,809 vol |
33,072 | |
Filed 2019-10-04 10:39 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
31,008 | |
Filed 2019-10-04 10:38 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
75,835 | |
Filed 2019-04-22 09:05 Tx date 2019-04-18 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,507
+10,000 vol $1.85 each |
153,014 | |
Filed 2019-03-17 Tx date 2019-03-14 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,993
+10,000 vol $1.90 each |
143,014 | |
Filed 2019-01-03 Tx date 2019-01-02 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
2,071,963 | |
Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,263 vol |
5,263 | |
Filed 2018-11-30 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,737 vol |
5,263 | |
Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
31,008 | |
Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,134 vol |
36,271 | |
Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-239,178 vol |
28,137 | |
Filed 2018-10-17 Tx date 2018-10-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,000 vol |
133,014 | |
Filed 2018-10-17 Tx date 2018-10-15 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-50,000 vol |
0 | |
Filed 2018-10-09 Tx date 2018-10-08 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,250
+10,000 vol $2.13 each |
83,014 | |
Filed 2018-07-16 Tx date 2018-07-13 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
Filed 2018-07-16 Tx date 2018-07-16 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,100
+10,000 vol $3.11 each |
73,014 | |
Filed 2018-01-23 Tx date 2018-01-22 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,671,963 | |
Filed 2018-01-23 Tx date 2018-01-19 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,271,963 | |
Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
267,315 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-50,000 vol |
0 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,783.20
-18,986 vol $1.20 each |
63,014 | |
Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,000 vol |
82,000 | |
Filed 2017-06-30 Tx date 2017-06-26 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,799
+20,000 vol $1.14 each |
32,000 | |
Filed 2017-06-09 Tx date 2017-06-06 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,500
+50,000 vol $1.03 each |
971,963 | |
Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
Filed 2017-03-31 Tx date 2013-10-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
921,963 | |
Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
229,586 | |
Filed 2016-10-06 Tx date 2016-10-03 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+79,586 vol |
129,586 | |
Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$229,200
+60,000 vol $3.82 each |
821,963 | |
Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
Filed 2015-12-14 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-12-02 Tx date 2015-11-30 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+4,000 vol $3.00 each |
12,000 | |
Filed 2015-11-27 Tx date 2015-11-24 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+100 vol $3.10 each |
8,000 | |
Filed 2015-11-27 Tx date 2015-11-24 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,480
+3,900 vol $3.20 each |
7,900 | |
Filed 2015-11-27 Tx date 2015-11-24 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,480
+3,900 vol $3.20 each |
||
Filed 2015-06-18 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+50,000 vol $0.80 each |
50,000 | |
Filed 2015-06-18 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-11 Tx date 2015-06-10 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$835,200
+120,000 vol $6.96 each |
761,963 | |
Filed 2015-05-12 Tx date 2014-10-01 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-7,061,587 vol |
641,963 | |
Filed 2015-05-12 Tx date 2015-05-11 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,534
+1,100 vol $5.94 each |
4,000 | |
Filed 2015-05-12 Tx date 2015-05-11 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,391
+900 vol $5.99 each |
2,900 | |
Filed 2015-05-12 Tx date 2015-05-08 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,040
+1,000 vol $6.04 each |
2,000 | |
Filed 2015-05-12 Tx date 2015-05-08 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,090
+1,000 vol $6.09 each |
1,000 | |
Filed 2015-05-12 Tx date 2015-05-08 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,900
+10,000 vol $6.09 each |
||
Filed 2015-05-12 Tx date 2015-05-08 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,900
+10,000 vol $6.09 each |
||
Filed 2015-05-12 Tx date 2013-10-28 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|